Over the course of three days, participants engaged in rich scientific discussions and interactive sessions aimed at advancing the understanding, diagnosis, and treatment of autoinflammatory diseases. The congress reaffirmed ISSAID’s core mission: to foster cross-specialty dialogue and promote global knowledge sharing in this rapidly evolving field.
Feedback from both the client and attendees was extremely positive. The success of the 2025 edition confirmed the importance of in-person meetings in advancing science and strengthening professional connections within specialised medical communities. The whole ISSAID community is now looking ahead to the next edition in 2027 in UK. MCI Switzerland looks forward to continuing our long-standing partnership with ISSAID, which is confirmed through to 2029.
